Document is current
Any future updates will be listed below
-
Authors
Oi-Yo, Yuka
Urai, Shin
Yamamoto, Akane
Takayoshi, Tomofumi
Yamamoto, Masaaki
Hirota, Yushi https://orcid.org/0000-0002-3035-4155
Ogawa, Wataru
- License Information
-
More Information
Article History
Received: 18 April 2024
Accepted: 14 July 2024
First Online: 25 July 2024
Compliance with ethical standards
:
: Y.H. has received lecture fees from Eli Lilly Japan K.K., Sanofi Aventis, Abbott Japan, Terumo Co., and Sumitomo Pharma Co. Ltd.; research funding from Sumitomo Pharma Co. Ltd., Medtronic Japan Co. Ltd., and Kyowa Kirin Co. Ltd.; and a donation from Abbott Japan. W.O. has received lecture fees from Sumitomo Pharma Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Abbott Japan, and Novo Nordisk Pharma Ltd.; research grants from Noster, Nippon Boehringer Ingelheim Co. Ltd., Boehringer Ingelheim Pharma GmbH & Co. KG, Eli Lilly Japan K.K., Abbott Diabetes Care UK Ltd., Sumitomo Pharma Co., Ltd., and Teijin Pharma Ltd.; and donations from Kowa Co. Ltd., Novo Nordisk Pharma Ltd., Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Teijin Pharma Ltd. Y.O.-Y., S.U., A.Y., T.T. and M.Y. declare no conflict of interest.
